Experts say combining functional medicine with cosmetic procedures delivers lasting, natural-looking results. Here’s how this ...

As chronic knee problems rise among young and middle-aged Indians, regenerative treatments such as Platelet-Rich Plasma (PRP) ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has ...

Many factors can disrupt hair growth – “from genetics and hormonal changes to stress, medical conditions or medication,” explains expert extensionist Hadley Yates. He’s recently seen an upswing in ...

Our incoming mayor is a proud graduate of the Bronx High School of Science and therefore knows a worthy science project when he sees one — especially one that was made in New York, employs New Yorkers ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem-cell-based therapy to treat severe aplastic anemia (SAA). The approval, which comes more than two years after Omisirge ...

Dec. 8 (UPI) --The U.S. Food and Drug Administration on Monday announced the approval of the first hematopoietic stem cell transplant therapy to treat patients with rare but severe aplastic anemia.

Kylie Jenner is the latest A-lister hopping on the stem cell therapy bandwagon. The 28-year-old mom of two revealed that she recently underwent the procedure in the hopes of easing the “bad chronic ...

Jenner offered a candid look at her treatment on Wednesday, Dec. 3 Madison E. Goldberg received her B.S. in Journalism and double minors in publishing and photography from Emerson College in 2022, Cum ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...